[go: up one dir, main page]

MA37531A1 - Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans - Google Patents

Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans

Info

Publication number
MA37531A1
MA37531A1 MA37531A MA37531A MA37531A1 MA 37531 A1 MA37531 A1 MA 37531A1 MA 37531 A MA37531 A MA 37531A MA 37531 A MA37531 A MA 37531A MA 37531 A1 MA37531 A1 MA 37531A1
Authority
MA
Morocco
Prior art keywords
essential oil
antibacterial effect
bitter orange
aaggregatibacter
actinomycetemcomitans
Prior art date
Application number
MA37531A
Other languages
French (fr)
Other versions
MA37531B1 (en
Inventor
Leila Lakhdar
Abdellah Farah
Oumkeltoum Ennibi
Original Assignee
Université Mohammed V De Rabat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Université Mohammed V De Rabat filed Critical Université Mohammed V De Rabat
Priority to MA37531A priority Critical patent/MA37531B1/en
Priority to PCT/MA2014/000058 priority patent/WO2016076689A1/en
Publication of MA37531A1 publication Critical patent/MA37531A1/en
Publication of MA37531B1 publication Critical patent/MA37531B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oncology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L’application de l’effet antibactérien de l'huile essentielle de bigaradier (citrus aurantium l.) d'origine marocaine sur une souche bactérienne orale virulente; aggregatibacteractinomycetemcomitans clone jp2. Cette souche originelle n'a jamais fait l’objet de tests, antimicrobiens à base d’huiles essentielles.Cette nouvelle application englobe aussi bien la méthodologie que les résultats obtenus. Latechnique utilisée est une méthode simple, claire, basée sur la preuve et offrant unemeilleure précision et une meilleure reproductibilité des résultats.The application of the antibacterial effect of the essential oil of bitter orange (citrus aurantium l.) Of Moroccan origin on a virulent oral bacterial strain; aggregatibacteractinomycetemcomitans clone jp2. This original strain has never been the subject of antimicrobial tests based on essential oils. This new application encompasses both the methodology and the results obtained. The technique used is a simple, clear, evidence-based method with improved accuracy and reproducibility of results.

MA37531A 2014-11-13 2014-11-13 Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans MA37531B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MA37531A MA37531B1 (en) 2014-11-13 2014-11-13 Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
PCT/MA2014/000058 WO2016076689A1 (en) 2014-11-13 2014-12-31 Pharmacological composition of oregano (essential oil) exhibiting an antibacterial effect on the jp2 clone of aggregatibacter actinomycetemcomitans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA37531A MA37531B1 (en) 2014-11-13 2014-11-13 Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans

Publications (2)

Publication Number Publication Date
MA37531A1 true MA37531A1 (en) 2016-06-30
MA37531B1 MA37531B1 (en) 2017-01-31

Family

ID=52684611

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37531A MA37531B1 (en) 2014-11-13 2014-11-13 Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans

Country Status (2)

Country Link
MA (1) MA37531B1 (en)
WO (1) WO2016076689A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119169B2 (en) * 2004-12-28 2012-02-21 Colgate-Palmolive Company Oregano oral care compositions and methods of use thereof
CA2824499C (en) * 2011-01-13 2016-04-12 Austin Research Labs Corp. High load dispersions

Also Published As

Publication number Publication date
WO2016076689A1 (en) 2016-05-19
MA37531B1 (en) 2017-01-31

Similar Documents

Publication Publication Date Title
EA201892201A1 (en) NON-INVASIVE DIAGNOSTICS OF NON-ALCOHOL STEATOPEPATITIS
MA52624A (en) METHODS OF TREATMENT OF ATOPIC DERMATITIS BY ADMINISTRATION OF AN IL-4R INHIBITOR
EP3341457A4 (en) REFINED OIL COMPOSITIONS AND METHODS OF MAKING SAME
EP3426227A4 (en) COMPOSITION AND METHOD OF USING ORAL COLCHICIN LIQUID
MA46641A (en) METHODS AND COMPOSITIONS FOR PREVENTING THE TRANSMISSION OF VECTOR-SPREAD DISEASES
ITUA20161822A1 (en) USEFUL COMPOSITIONS IN THE PREVENTION AND / OR IN THE TREATMENT OF ORAL CABLE PATHOLOGIES, OF THE FIRST AIRWAYS AND OF THE ESOFAGO
EP3794345A4 (en) OPTIMIZED SIGMA-1 AGONIST METHOD OF RESPONDER SELECTION AND TREATMENT
AR107716A1 (en) LUBRICANT FOR A TWO-TIME MARINE ENGINE
MX387496B (en) TOPICAL COMPOSITIONS COMPRISING PICHIA ANOMALA AND RETINOL.
AR112996A1 (en) ANTIBODY-DRUG CONJUGATE EVALUATION METHODS
EP3228684C0 (en) LUBRICANT COMPOSITIONS USING IMPROVED FRICTION PROPERTIES AND METHODS OF USE
MA37531A1 (en) Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
EP3677910A4 (en) METHOD OF DIAGNOSING PANCREE CANCER USING METHIONYL ARNT SYNTHETASE, AND PANCREE CANCER DIAGNOSIS KIT USING IT
MA37532A1 (en) Pharmacological composition of palmarosa (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
MA37533B1 (en) Pharmacological composition of oregano (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
KR102403795B9 (en) Anti-allergic or antioxidant composition containing hemp seed extract
MA37534B1 (en) Pharmacological composition of thyme (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
MA37530A1 (en) Pharmacological composition of citronella (essential oil) with antibacterial effect on aggregatibacter actinomycetemcomitans
EP3672994A4 (en) HIGH CONCENTRATED, LOW VISCOSITY MASP-2 INHIBITOR ANTIBODY FORMULATIONS, KITS AND METHODS OF TREATMENT OF SUBJECTS WITH ATYPICAL HEMOLYTIC SYNDROME
MA37529B1 (en) Pharmacological composition of pennyroyal mint (essential oil) with antibacterial effect on the aggregatibacter actinomycetemcomitans.
CL2018002949A1 (en) Compositions for oral care.
EP3712578A4 (en) SPECTRAL ANALYSIS DEVICE AND SPECTRAL ANALYSIS METHOD
FR3064481B1 (en) USE OF AN EXTRACT OF CHLORELLA SOROKINIANA IN COSMETICS AND SPECIAL EXTRACTS OF CHLORELLA SOROKINIANA
AU2015205151A1 (en) 5-hydroxy-1H-imidazole-4-carboxamide effective-dose/sensitivity prediction method and prediction device, xanthosine-monophosphate-amount measurement method, and myelodysplastic-syndrome treatment agent and treatment method
EP3731639A4 (en) MIXTURES OF SEBADILLA ALKALOIDS AND ESSENTIAL OILS AND THEIR USES